WLKP Westlake Chemical Partners LP
Industrial Organic Chemicals · NYSE · SEC CIK 1604665 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.4%
TTM net income YoY20.4%
TTM EPS YoY—
Revenue 3-yr CAGR-0.5%
Net income 3-yr CAGR1.4%
Margins
Gross margin31.4%
Operating margin29.0%
Net margin4.8%
FCF margin35.8%
EBITDA margin38.0%
Returns
ROE—
ROA4.7%
ROIC (approx.)—
Asset turnover0.99x
Leverage & solvency
Liabilities / assets37.1%
Debt / equity—
Current ratio3.52x
Interest coverage17.25x
Cash quality & payout
Operating cash flow / net income8.16x
Accruals ratio-33.9%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.17B | $1.14B | $1.19B | $1.59B | $1.21B |
| Cost of revenue | $818.85M | $716.96M | $803.33M | $1.22B | $773.15M |
| Gross profit | $347.85M | $418.94M | $387.46M | $377.37M | $441.71M |
| SG&A expense | $28.27M | $28.50M | $29.75M | $29.68M | $31.02M |
| Operating income | $319.58M | $390.44M | $357.71M | $347.69M | $410.69M |
| Interest expense | $22.90M | $25.70M | $26.50M | $13.41M | — |
| Pretax income | $299.12M | $369.99M | $335.44M | $335.85M | $401.93M |
| Income tax | $547,000 | $835,000 | $813,000 | $1.02M | $549,000 |
| Net income | $48.70M | $62.39M | $54.28M | $64.17M | $82.55M |
| EBITDA | $447.56M | $502.34M | $467.91M | $468.76M | $519.50M |
| EPS (diluted) | — | — | — | — | — |
| Weighted avg. shares (diluted) | — | — | — | — | 35.21M |
| Balance sheet | |||||
| Cash & equivalents | $44.27M | $58.32M | $58.62M | $64.78M | $17.06M |
| Receivables | $9.11M | $11.58M | $18.70M | $20.03M | $5.83M |
| Inventory | $2.77M | $4.06M | $4.43M | $4.71M | $8.90M |
| Current assets | $143.51M | $240.93M | $226.20M | $245.79M | $281.21M |
| PP&E, net | $886.01M | $903.59M | $943.84M | $990.21M | $1.04B |
| Goodwill | $5.81M | $5.81M | $5.81M | $5.81M | $5.81M |
| Total assets | $1.26B | $1.29B | $1.32B | $1.37B | $1.48B |
| Current liabilities | $51.30M | $55.37M | $56.34M | $66.94M | $106.80M |
| Total liabilities | $454.18M | $458.64M | $460.59M | $468.27M | $508.00M |
| Shareholders' equity | — | — | — | — | — |
| Cash flow statement | |||||
| Operating cash flow | $280.47M | $485.00M | $452.00M | $463.74M | $408.44M |
| Capital expenditure | $78.82M | $48.97M | $46.82M | $54.12M | $81.17M |
| Free cash flow | $201.65M | $436.03M | $405.18M | $409.62M | $327.27M |
| Investing cash flow | $31.18M | -$88.97M | -$75.94M | -$12.00M | -$64.30M |
| Financing cash flow | -$325.70M | -$396.33M | -$382.23M | -$404.01M | -$344.24M |
| Depreciation & amortization | $127.98M | $111.90M | $110.20M | $121.07M | $108.81M |
Free plan shows the latest 5 periods; Pro shows all 14 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.